Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases

TUESDAY, Nov. 28, 2023 -- For patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs (DMARDs), receiving a fourth COVID-19 mRNA vaccine reduces the risk for severe acute respiratory syndrome coronavirus 2...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news